Skip to content

Insider · CIK 0001711254

Paull Robert Bradley

Reports to the SEC for 1 company · WALTHAM, MA

Transactions

16

Companies

1

Filings

8

CIK

0001711254

Forms 4 and 5

Insider transactions

16 trades
DateCompanyValue
2022-06-16KALAKALA BIO, Inc. · Stock Option (right to buy)A Award—
2021-06-17KALAKALA BIO, Inc.A Award—
2020-06-25KALAKALA BIO, Inc.A Award—
2020-03-11KALAKALA BIO, Inc.J Other—
2019-06-05KALAKALA BIO, Inc. · Stock Option (right to buy)A Award—
2018-06-12KALAKALA BIO, Inc. · Stock Option (right to buy)A Award—
2018-06-11KALAKALA BIO, Inc.J Other—
2018-05-18KALAKALA BIO, Inc.J Other—
2017-07-25KALAKALA BIO, Inc.C Conversion—
2017-07-25KALAKALA BIO, Inc. · Series Seed Preferred StockC Conversion—
2017-07-25KALAKALA BIO, Inc. · Series A Preferred StockC Conversion—
2017-07-25KALAKALA BIO, Inc. · Series B Preferred StockC Conversion—
2017-07-25KALAKALA BIO, Inc. · Series C Preferred StockC Conversion—
2017-07-25KALAKALA BIO, Inc. · Series B Preferred Stock Warrant (right to buy)C Conversion—
2017-07-25KALAKALA BIO, Inc. · Common Stock Warrant (right to buy)C Conversion—
2017-07-19KALAKALA BIO, Inc. · Stock Option (right to buy)A Award—

Recent filings

8

Companies

1

Address

C/O KALA PHARMACEUTICALS, INC. 100 BEAVER STREET, SUITE 201

WALTHAM, MA, 02453